FTC Asks FDA To Clarify "Orange Book" Listing Criteria In Citizen Petition
Patents that claim any unapproved aspects of an approved drug should not be listed in the "Orange Book," the Federal Trade Commission maintained.
Patents that claim any unapproved aspects of an approved drug should not be listed in the "Orange Book," the Federal Trade Commission maintained.